Epidemiological evidence shows that small size at birth is associated with an increased risk of developing cardiovascular and metabolic disease in adult life. We have examined the relationships between size at birth and maternal body composition and protein turnover in normal pregnant women. A group of 27 multiparous Caucasian women with singleton pregnancies were studied at around 18 and 28 weeks' gestation. Body composition was determined by anthropometry, and whole-body protein turnover was estimated by using a single oral dose of [
INTRODUCTION
Many epidemiological studies have shown that babies that are small, or thin, at birth are more likely as adults to develop hypertension, coronary heart disease and Type II diabetes [1] . These associations are seen within the normal range of birth sizes, and have led to increased interest in the factors that influence the growth and development of the fetus. Of these factors, the delivery of energy and nutrients across the placenta to the fetus is likely to be important [2] , and it is sometimes assumed that this is determined mainly by the mother's intake of food. Previous studies, however, have not shown strong associations between the dietary intake of well nourished pregnant women and either birth or placental weight, suggesting that if fetal growth is related to maternal nutrition, then nutritional status has to be defined in broader terms than simply dietary intake [3, 4] . Other aspects of nutritional status that may be important in relation to fetal growth are the size and body composition of the mother, and her capacity to carry out metabolic transformations.
Metabolic capacity can be characterized in different ways for different functions, such as the ability to handle a glucose load or the pattern of postprandial lipid metabolism. Growth represents the net acquisition of lean tissue, and we have characterized mothers' metabolic capacity in the present study using the measurement of whole-body protein turnover, which describes the rate at which proteins are synthesized and degraded in the body [5] . Since one of the major determinants of metabolism is body size, both height and weight, we have assessed protein turnover in mid and late pregnancy in normal women of similar height, but different weight, and related it to maternal body composition, and the size of the baby at birth.
METHODS

Subjects
We approached 179 multiparous Caucasian women who attended the midwives' antenatal booking clinic at the Princess Anne Maternity Hospital and Bitterne Health Centre, Southampton, and Romsey Hospital, Romsey, Hampshire, U.K. Those eligible had to be non-smokers, between 24 and 33 years of age, with a height of 1.58-1.68 m and a body mass index of 21.0-29.0 kg\m#. A total of 33 women fulfilled these selection criteria, of whom 30 agreed to take part. Of these, one miscarried and two left the study for medical reasons. The study was approved by the local ethics committee, and each subject gave informed written consent before participating in the study.
Study protocol
The study was designed to be as non-invasive as possible and was carried out in the subject's home. The women were visited at home and a food frequency questionnaire was administered to assess dietary intake [6] . After the home visit, the women completed a 3-day food diary. Energy and protein intakes were determined using standard food portion sizes and a computerized dietary analysis package [7, 8] . Body composition was determined by anthropometry, and whole-body protein turnover by using a single dose of ["&N]glycine and the end-product method.
The 3-day food diary was completed once, and the other measurements were carried out twice during pregnancy : at 16-19 weeks' gestation (mid pregnancy) and at 26-29 weeks' gestation (late pregnancy). At birth the baby was weighed to the nearest 5 g using digital scales. Crown-heel length was measured to the nearest 0.1 cm by two trained research nurses in triplicate using a neonatal stadiometer, and the mean value was used in the analysis. The placenta was weighed on digital scales after removing the umbilical cord and membranes. The length of gestation was estimated from menstrual history.
Maternal body composition
Height was measured with a stadiometer to the nearest 0.1 cm, weight with digital scales to the nearest 0.1 kg, and four skinfold thicknesses (biceps, triceps, subscapular and supra-iliac) with Harpenden skinfold calipers to the nearest 0.1 mm by one field worker. Body density was estimated from skinfold thicknesses [9] , and fat mass was derived from body density [10] using standard equations. Lean body mass was derived as weight minus fat mass. Creatinine excretion was measured by the Jaffe reaction using a 24 h urine collection [11] , and was used to estimate muscle mass on the basis that 1 kg of muscle is associated with the excretion in urine of 60 mg of creatinine\day [12] . Non-muscle mass was calculated as lean body mass minus muscle mass, and is referred to as visceral mass [13] .
Whole-body protein turnover
The women ingested a single dose of ["&N]glycine (125 mg ; 99 atom % excess ; Delta Isotopes, Crewe, Cheshire, U.K.) dissolved in water at a known time between 07.30 and 09.30 hours. A sample of urine was collected before the administration of any isotope to determine the background abundance of "&N. All urine passed for the 24 h following ingestion of the ["&N]-glycine was collected directly on to thymol (98 % ; SigmaAldrich Co. Ltd, Gillingham, Dorset, U.K.) [14] . Food was provided during the measurement of protein turnover to match reported intake. Some women asked for more food during the 24 h period of the study, which was provided, whereas others did not eat all the food given. Energy and protein intakes during the study were calculated from the amount of food given minus the amount that was left.
Analyses
The volume of the 24 h urine collection was measured, then 60 ml samples were taken, acidified with 100 µl of HCl (6 M) and stored at k20 mC until analysis. The concentrations of urea and ammonia in urine were measured by the Berthelot method [15] . Ammonia and urea were isolated sequentially from urine. Ammonia was extracted by alkaline aeration. The urine was then incubated with urease at pH 6.5 for 90 min at 37 mC, and the ammonia formed was collected by alkaline aeration [16] . Nitrogen gas was liberated from ammonia with alkaline hypobromite and the enrichment was measured in a triple collector mass spectrometer against a known standard (SIRA 10 ; VG Isogas, Winsford, Cheshire, U.K.).
The enrichment in urine of "&N in urea-nitrogen and ammonia was measured and used to derive values for nitrogen flux. The arithmetic mean of the values for nitrogen flux derived from the two end products, urea and ammonia, was used in further calculations [14, [17] [18] [19] [20] . Protein synthesis was calculated as nitrogen flux minus urinary urea and ammonia nitrogen excretion. Protein breakdown was calculated as nitrogen flux minus nitrogen consumed as protein.
Statistical analysis
Paired t tests were used to compare the differences between mid and late pregnancy. We used linear regression analysis to explore associations between maternal body composition, protein turnover and the size of the baby at birth. Analyses include the maximum number of subjects possible at each stage. For linear regression analyses, protein intake and turnover are expressed as g of nitrogen\day (gN\day) ; 1 g of nitrogen is equivalent to 6.25 g of protein.
The statistical package SPSS version 7.5 was used for statistical analyses.
RESULTS
The characteristics of the 27 mothers and babies are shown in Table 1 . The weight of the women comprised about one third each of fat, muscle and visceral mass. Between mid and late pregnancy there were significant increases in the mothers' weight, body mass index, fat Maternal body composition and whole-body protein turnover were determined at 16-18 weeks' gestation (mid pregnancy) and at 26-28 weeks' gestation (late pregnancy). Values are meanspS.D. Protein turnover was not completed successfully in two women, one in mid pregnancy and one in late pregnancy ; analyses of changes in protein turnover refer to 25 subjects. For measurements of protein synthesis and breakdown, 1 g of nitrogen is equivalent to 6. 
Protein turnover
The measurement of protein turnover was completed successfully in both mid and late pregnancy by 25 subjects. Table 1 shows the values for protein turnover during mid and late pregnancy. Protein synthesis and protein breakdown both increased significantly between mid and late pregnancy, by 15 % and 17 % respectively. There was considerable variation between individuals in all measures of whole-body protein turnover. Taller women had higher rates of protein turnover, even within the range of heights selected. There was no relationship between body weight and protein turnover. Maternal fatness, whether expressed as fat mass, percentage fat or skinfold thickness, was not associated with protein turnover (Tables 2 and 3 ).
Mid pregnancy
In mid pregnancy, mothers with a greater lean body mass had higher rates of protein turnover (Table 2) . When height was included in the regression, the association between protein turnover and lean body mass remained similar, but height was no longer associated with protein turnover. For every 1 kg increase in lean body mass, independent of height, protein synthesis increased by 0.73 gN\day [95 % confidence intervals (CI) 0.00-1.46 gN\day ; P l 0.05], and protein breakdown in- The women were divided into four groups on the basis of visceral mass, as indicated. Values are meanspS.E.M.
creased by 0.64 gN\day (95 % CI 0.06-1.22 gN\day ; P l 0.03). When lean body mass was separated into muscle mass and visceral mass, the association between protein turnover and lean body mass was mainly accounted for by differences in visceral mass (Table 2) . In Figure 1 , the subjects have been divided into four groups based on visceral mass, and the mean values for protein synthesis and protein breakdown are shown for each group. There was a difference in the rate of protein synthesis of 9.7 gN\day between the group with the lowest and the group with the highest visceral mass. The more protein the mother ate, the higher the rate of protein synthesis, but not protein breakdown (Table 2) . However, even after adjusting for the mother's height and protein intake, in a multivariate analysis, the mother's visceral mass predicted the rate of protein turnover (Table 2) .
Late pregnancy
In late pregnancy, there was a trend for mothers with a greater lean body mass to have higher rates of protein turnover, but there was no indication that these associations could be attributed to muscle mass or visceral mass (Table 3) . When height was included in an analysis with visceral and muscle mass, it was the dominant predictor of protein turnover, independent of the mother's protein intake (Table 3) .
Birth size
Birth weight and length and placental weight rose with increasing gestational age at birth, and were higher for boys than for girls. We therefore adjusted these values for duration of gestation and the baby's sex in the subsequent analyses. Mothers who had greater protein turnover in Protein turnover in pregnancy and birth length The women were divided into four groups on the basis of rate of protein synthesis, as indicated. Values are meanspS.E.M.
mid pregnancy had babies that were longer at birth. In Figure 2 , the subjects have been divided into four groups based on their rate of protein synthesis in mid pregnancy, and the mean values for the length of the baby at birth are shown for each group. Maternal protein synthesis accounted for 26 % of the variation in adjusted birth length, and over a normal range of protein synthesis in mid pregnancy (p2S.D.) this amounted to an estimated difference of 1.9 cm in the length of the baby. This association was independent of the mother's height, lean body mass and protein intake (Table 4 ). There were no statistically significant relationships between maternal protein turnover in late pregnancy and the length of the baby at birth, nor between protein turnover at either stage of pregnancy and birth weight. There were no statistically significant associations between the body composition of the mother or her dietary protein intake, and birth weight or birth length or the weight of the placenta. Although taller mothers tended to have longer babies, this association did not achieve statistical significance (r l 0.35 ; P l 0.08).
DISCUSSION
We used a non-invasive approach to measure protein turnover in 27 pregnant women and examined the association between maternal body composition and protein turnover. We also explored the relationship between the mother's dietary intake of protein, her body composition and her protein turnover at two time points in pregnancy, and the size of the baby at birth. While we expected to see an association between the body size of the mother and her protein turnover, we have shown for the first time that mothers with a greater lean body mass, but not fat mass, had higher rates of protein turnover Birth length is adjusted for baby's sex and duration of gestation. The expected change in birth length is for a unit increase in maternal protein synthesis or body composition after adjustment for other variables in the at 18 weeks' gestation. Further, it was the visceral component of lean body mass that was positively associated with protein turnover, and not the muscle. We also showed that women who turned over more protein at 18 weeks' gestation had babies that were longer at birth. There was, however, no association between the mother's protein intake and the baby's length. This is the first time that a specific measure of the mother's metabolism has been related to linear fetal growth. There are two approaches to the measurement of whole-body protein turnover, so-called precursor methods and end-product methods [21] . The precursor method is relatively invasive : it requires repeated blood samples and subjects are usually admitted to a metabolic ward for the duration of the study. In contrast, the endproduct method was developed to be non-invasive, requiring minimal co-operation from subjects, who can remain at home for the duration of the measurement. This substantially increases the rates of participation, particularly when studying pregnant women [17, 20] . We therefore chose to use a single oral dose of ["&N]glycine and the end-product method in the present study, enabling us to investigate a large number of women. In addition, we have shown previously that similar results are obtained with the end-product method [14] when compared with results obtained by others using intravenously administered ["$C]leucine followed by frequent blood sampling [22] .
We found that mothers who had a higher rate of protein turnover in mid pregnancy had babies that were longer at birth. The rate of protein turnover was determined by the mother's body size and by the size of specific body composition compartments. Mothers with the greatest lean body mass had the highest rates of protein turnover in mid pregnancy, and this was attributed directly to having a greater visceral mass. Although taller mothers had higher rates of protein turnover, the relationship between protein turnover and the baby's length at birth was independent of maternal height, lean body mass and dietary protein intake. There is considerable variability in protein turnover in pregnancy between individuals, but as yet little attention has been given to exploring what factors might explain this variability, other than differences in body weight. We are not aware of any studies that report an association between protein turnover and fetal growth, possibly because the number of subjects that have been studied previously has been relatively small [22] [23] [24] [25] . A mother's body size is an important determinant of the size of her baby, and it has been shown that in well nourished women maternal lean body mass is a better predictor of the baby's size than fat mass [26] . Our findings suggest that the visceral component of lean body mass influences the rate at which protein turns over in the mother, and it is this which drives fetal growth. A higher rate of protein turnover might be advantageous, as the greater the rate of synthesis and breakdown of protein, the more likely it is that specific amino acids could be made available to the fetus at any time.
The maximum rate of gain in length of the fetus occurs at about 20 weeks' gestation [27] , and this may explain why we found an association between the baby's length and maternal protein turnover in mid, but not late, pregnancy. It is likely that a perturbation at the time of maximal growth of a tissue would have more impact on the final size of that tissue than when it is growing more slowly and when its growth is nearing completion. After adjustment for duration of gestation and sex, we were able to explain a substantial proportion (26 %) of the variability in the adjusted length of the baby at birth through differences in maternal protein turnover in mid pregnancy. This compares with other findings that have shown that smoking might explain 14 % in the variance in adjusted birth weight, and changes in nutrient intake between 28 and 36 weeks' gestation a further 2.4-7.2 % [28] .
It was during mid pregnancy that we found a strong association between maternal visceral mass and protein turnover. In contrast, in late pregnancy, maternal height was the strongest predictor of turnover. These findings might reflect the relatively low reliability with which body composition can be measured compared with height in late pregnancy : the more precise the measurement, the more likely it is that a statistically significant relationship will be seen. Height can be measured with great precision throughout pregnancy, but in late ges-tation there is increased error associated with estimating body composition from skinfold thicknesses using standardized equations [9, 10] . In addition, the fetus and placenta will contribute more to the estimate of visceral mass. Both of these factors will reduce the precision with which visceral mass can be derived. Maternal height therefore may be a useful marker in late pregnancy for the mother's metabolic capacity, by reflecting visceral mass. In the present study, the term visceral mass does not represent any specific metabolic compartment, but includes tissues as diverse as bone, brain and the growing concepta, as well as the viscera. Even given the relatively unspecific nature of the visceral mass, we have shown strong associations with protein turnover. In metabolic terms, it is likely that the liver will influence rates of protein turnover. It has been shown that liver may contribute up to 25 % of whole-body protein turnover [29] . One important question will be whether turnover rates are influenced predominantly by the size of the visceral compartment or by its metabolic activity [13] .
The liver plays a central role in metabolic homoeostasis, determining the availability of nutrients to the body and their partitioning between tissues. This may be important with respect to studies that have reported associations between the mother's intake of micronutrients, but not macronutrients, and fetal growth [4, 28, 30] . Micronutrients have a range of functions, among which their ability to act as accessory factors that facilitate enzymic function, enhancing the body's capacity for metabolic transformations, is of particular relevance to liver function during pregnancy. During pregnancy there is net gain of protein in both the mother and fetus, resulting in a high demand for relatively large amounts of non-essential amino acids (NEAA) for protein synthesis. NEAA do not need to be taken preformed in the diet, but are usually made in sufficient amounts within the body [31] [32] [33] . To satisfy the additional demands for NEAA during pregnancy requires that adequate micronutrients are available for their endogenous synthesis, which takes place in the liver and also the placenta.
The growth of the fetus and maternal tissues increases the need for protein and energy during pregnancy. Our study shows that these needs were not met by an increase in dietary intake. The size of the newborn baby was determined by the rate of metabolic exchange and turnover in the mother. These findings suggest that maternal nutrition should be considered in broader terms than simply maternal dietary intake during pregnancy.
